Search
Searched for "16a".
06/10/2025
Abgeschlossen ACcomplisH: A Phase 2, multicenter, double-blind, randomized, placebo- controlled, dose escalation trial evaluating 2019-002754-22 Ascendis Pharma Growth Disorders A/S, Tuborg Boulevard 12, [...] (Obsidian ASG®) for treatment of anastomosis during rectal surgery – a single-blind, randomized, multicenter pilot study ORSY Vivostat A/S, Borupvang 2, 3450 Alleroed, Denmark Prüfzentrum: Krankenhaus der [...] 1200 Wien l ÖSTERREICH l www.basg.gv.at F_INS_VIE_CLTR_I125_05 Gültig ab: 16.01.2025 4 von 6 Oryahovitsa, Bulgarien und Sponsor A double-blind, randomized, placebo- controlled study to assess the safety
Referenced at:
29/10/2019
Gemäß § 8. (2) Gewebeviglianzverordnung ist das BASG dazu verpflichtet, die von der Europäischen Kommission verfasste Zusammenfassung der von den Mitgliedstaaten eingegangenen Berichte zu veröffentlichen (Bericht nur auf englisch verfügbar).
Referenced at:
13/05/2019
Symptoms associated with Zika virus (ZIKV) infection are generally mild and most people who become infected do not develop any symptoms. However, since the 2015‒2017 epidemic in the Americas, ZIKVhas been recognised asbeingassociated with severe neurological disorders
Referenced at:
Recall
|
Medicines
|
23/12/2021
Recall of two batches due to a deviation of the active substance content diphenhydramine
28/08/2015
Chikungunya case in Spain without travel history to endemic areas
Referenced at:
31/03/2016
From 1 January 2007 to23 March 2016, Zika virus transmission was documented in a total of 61 countries and territories.
Referenced at:
03/10/2022
Dem Bundesamt für Sicherheit im Gesundheitswesen wurde von der ECDC (European Centre for Disease Prevention and Control) mitgeteilt, dass in Kroatien 2 weitere humane WNV-Infektionen verzeichnet wurden.
Referenced at:
25/10/2022
Dem Bundesamt für Sicherheit im Gesundheitswesen wurde von der ECDC (European Centre for Disease Prevention and Control) mitgeteilt, dass in Griechenland 4 weitere humane WNV-Infektionen verzeichnet wurden.
Referenced at:
16/06/2015
require a license, if... 2. a medical doctor, dentist or veterinarian, licensed for independent exercise of profession in Austria, confirms, that the medicinal product is urgently required to avert a life [...] intended to facilitate the urgently needed treatment of a specific patient to avert a life-threatening or chronically debilitating situation. A Cave: English translations of Austrian legal documents are [...] , in contrast, provides a framework where data (primarily on safety) on the medicinal product, can be collected (according to a treatment plan) after approval by the Agency. A Compassionate Use Program
Referenced at:
Safety warnings
|
Medical devices
|
11/09/2018
The Federal Office for Safety in Health Care (BASG) has been informed that "LOGIMED Medizinische Spezialprodukte Gesellschaft m.b.H., Gösserstraße 11, 8700 Leoben" (Logimed), which was liquidated in 2011, has no legal successor who continues to fulfil the manufacturer obligations arising from the Medical Devices Act (MPG), Federal Law Gazette No. 657/1996, as amended. These obligations include Post Market Surveilance System (PMS), which includes the investigation of incidents and, where appropriate, the initiation of safety corrective actions in the field.